243 results
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
totaled $4.3 million.
About TherapeuticsMD
TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
is appropriate or necessary.
About TherapeuticsMD
TherapeuticsMD was previously a women’s healthcare company with a mission of creating
8-K
TXMD
TherapeuticsMD Inc
18 Aug 23
Entry into a Material Definitive Agreement
5:18pm
of IT Services to healthcare providers, from April 2021 to December 2021 and as the Chief Financial Officer of Encompass Onsite, a provider of end-to-end … property solutions, from November 2018 to February 2021. Prior to joining Encompass, he held multiple roles as a CFO in the healthcare industry, including
8-K
EX-99.1
l0vko9d9mcicjxge2
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
EX-99.1
gbrhy6raq4n
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
EX-10.2
4ct7pk0r80pil
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
xatdofod
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
iublyj2 jyjp7
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-10.1
5ciqsyky mo3
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
z6j60zzadft
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
d1nulhago2qptu2oi
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am